McDonald J A, Quade B J, Broekelmann T J, LaChance R, Forsman K, Hasegawa E, Akiyama S
J Biol Chem. 1987 Mar 5;262(7):2957-67.
Fibroblasts organize the modular cell-adhesive glycoprotein fibronectin into a highly structured pericellular matrix by poorly understood mechanisms. Previous studies implicated an amino-terminal domain in matrix assembly and suggested that fibronectin's cell-adhesive domain and the corresponding fibroblast receptor were not involved in this process. To further elucidate the fibronectin region(s) involved in matrix assembly, we mapped a library of proteolytic fragments and antibodies to various fibronectin domains. The fragments and antibodies were used to probe the role of fibronectin's amino-terminal and cell-adhesive domains in a fibroblast matrix assembly assay. We found that fibronectin fragments including the first 25-kDa sequence of fibronectin and antibodies to amino-terminal domains inhibited pericellular matrix assembly. Polyclonal antibodies to the 40-kDa collagen binding domain following the 25-kDa amino-terminal domain also inhibited matrix assembly. However, collagen binding is not required for matrix assembly as neither monoclonals blocking collagen binding nor purified collagen binding domains themselves inhibited matrix assembly. Therefore, the amino-terminal region of fibronectin contains a site important in matrix assembly, and most activity is present in the first 25-kDa of fibronectin. Fibronectin's cell-adhesive domain and the fibroblast receptor binding to this domain also play an important role in fibronectin matrix assembly. Apart from a monoclonal antibody to the amino-terminal domain, only monoclonal antibodies binding to fibronectin's cell-adhesive domain and inhibiting cell adhesion also inhibited matrix assembly. In addition a 105-kDa fragment containing the cell-adhesive domain inhibited matrix assembly. We conclude that at least two discrete and widely separated sites in fibronectin with different binding properties--the carboxyl-terminal fibroblast cell-adhesive domain and an amino-terminal matrix assembly domain localized primarily within the first 25 kDa--are required for fibronectin pericellular matrix assembly by fibroblasts. Fibronectin's cell-adhesive domain and its cell surface-receptor complex appear to be involved in the matrix assembly process prior to a step involving the amino-terminal domain. We believe that this step is likely to be the initiation of cell-associated fibronectin fibril formation by the fibronectin-adhesive-receptor complex.
成纤维细胞通过尚不清楚的机制将模块化细胞黏附糖蛋白纤连蛋白组织成高度结构化的细胞周基质。先前的研究表明,一个氨基末端结构域参与基质组装,并提示纤连蛋白的细胞黏附结构域和相应的成纤维细胞受体不参与此过程。为了进一步阐明参与基质组装的纤连蛋白区域,我们绘制了一个蛋白水解片段文库以及针对纤连蛋白各个结构域的抗体。这些片段和抗体被用于在成纤维细胞基质组装试验中探究纤连蛋白氨基末端和细胞黏附结构域的作用。我们发现,包含纤连蛋白前25 kDa序列的纤连蛋白片段以及针对氨基末端结构域的抗体抑制细胞周基质组装。针对25 kDa氨基末端结构域之后的40 kDa胶原结合结构域的多克隆抗体也抑制基质组装。然而,基质组装并不需要胶原结合,因为阻断胶原结合的单克隆抗体或纯化的胶原结合结构域本身均未抑制基质组装。因此,纤连蛋白的氨基末端区域含有一个对基质组装很重要的位点,且大部分活性存在于纤连蛋白的前25 kDa中。纤连蛋白的细胞黏附结构域以及与其结合的成纤维细胞受体在纤连蛋白基质组装中也发挥重要作用。除了一种针对氨基末端结构域的单克隆抗体外,只有与纤连蛋白细胞黏附结构域结合并抑制细胞黏附的单克隆抗体也抑制基质组装。此外,一个包含细胞黏附结构域的105 kDa片段抑制基质组装。我们得出结论,成纤维细胞组装纤连蛋白细胞周基质需要纤连蛋白中至少两个具有不同结合特性的离散且相隔较远的位点——羧基末端成纤维细胞黏附结构域和主要位于前25 kDa内的氨基末端基质组装结构域。纤连蛋白的细胞黏附结构域及其细胞表面受体复合物似乎在涉及氨基末端结构域的步骤之前参与基质组装过程。我们认为,这一步骤很可能是纤连蛋白黏附受体复合物启动细胞相关纤连蛋白原纤维的形成。